Rankings
▼
Calendar
LFMD Q3 2025 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena
LFMD
LifeMD, Inc.
$182M
Q3 2025 Earnings
Healthcare
Medical - Pharmaceuticals
Income Statement
Revenue
$60M
+13.0% YoY
Gross Profit
$53M
87.7% margin
Operating Income
-$2M
-3.3% margin
Net Income
-$4M
-6.3% margin
EPS (Diluted)
$-0.10
QoQ Revenue Growth
-3.3%
Cash Flow
Operating Cash Flow
-$147,136
Free Cash Flow
$6M
Stock-Based Comp.
$3M
Balance Sheet
Total Assets
$66M
Total Liabilities
$63M
Stockholders' Equity
$1M
Cash & Equivalents
$24M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$60M
$53M
+13.0%
Gross Profit
$53M
$48M
+9.3%
Operating Income
-$2M
-$4M
+50.7%
Net Income
-$4M
-$5M
+18.3%
Revenue Segments
Product and Services
$3M
100%
← FY 2025
All Quarters
Q4 2025 →